Yahoo Web Search

Search results

  1. en.wikipedia.org › wiki › ZymergenZymergen - Wikipedia

    Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.

  2. Oct 13, 2021 · The company behind the ad was Zymergen, a California synthetic biology company that had just gone public with a market capitalization of $3 billion. Its three founders — Josh Hoffman, Zach ...

  3. Oct 19, 2022 · Ginkgo Bioworks, a company that designs and builds biological systems, announces its completed acquisition of Zymergen, a company that develops automation and software solutions for biological engineering. The acquisition is expected to enhance Ginkgo's platform and expand its product concepts and partnerships.

  4. Jul 25, 2022 · Zymergen, a synthetic biology company that shifted to drug discovery in January, has been acquired by Ginkgo Bioworks for $300 million. Ginkgo plans to integrate Zymergen's automation and software into its cell engineering platform, while evaluating alternatives for its drug discovery business.

    • James Waldron
  5. Oct 19, 2022 · Ginkgo Bioworks, a biotech company that programs cells, has completed its acquisition of Zymergen, a biotech company that designs and produces molecules, microbes and materials. The acquisition is expected to enhance Ginkgo's platform and expand its applications across diverse markets.

  6. Jan 10, 2022 · SAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is...

  7. Oct 19, 2022 · Ginkgo Bioworks, a biotech company that designs and produces molecules, microbes and materials, has completed its acquisition of Zymergen, a biotech company that partners with nature to make better products. The acquisition is expected to enhance Ginkgo's platform with automation, software and biological engineering capabilities.

  8. People also ask

  1. People also search for